Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.19.2
Equity Incentive Plan (Tables)
6 Months Ended
Jun. 30, 2019
Equity Incentive Plan  
Schedule of stock option activity

The following is a summary of stock option activity under the Plans for the six months ended June 30, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Number of

 

Weighted- Average

 

Contractual Life

 

    

Options

    

Exercise Price

    

(In Years)

Outstanding at December 31, 2018

 

2,076,153

 

$

2.28

 

6.51

Granted

 

750,000

 

 

0.48

 

  

Expired

 

(48,737)

 

 

1.08

 

  

Outstanding at June 30, 2019

 

2,777,416

 

$

1.81

 

7.10

Exercisable at June 30, 2019

 

1,651,546

 

$

2.65

 

5.62

Vested and Expected to Vest at June 30, 2019

 

2,777,416

 

$

1.81

 

7.10

 

 

  

 

 

  

 

  

Outstanding at December 31, 2017

 

1,893,003

 

$

2.49

 

5.40

Granted

 

275,500

 

 

0.57

 

 

Forfeited

 

(1,500)

 

 

0.83

 

 

Expired

 

(60,968)

 

 

0.80

 

 

Outstanding at June 30, 2018

 

2,106,035

 

$

2.29

 

4.66

Exercisable at June 30, 2018

 

1,429,484

 

$

2.65

 

3.95

Vested and Expected to Vest at June 30, 2018

 

2,106,035

 

$

2.29

 

4.66

 

Schedule of weighted average assumptions

For the six months ended June 30, 2019 and 2018, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes Option Pricing Model with the following weighted-average assumptions:

 

 

 

 

 

 

 

 

    

2019

    

2018

 

Risk-Free Interest Rate

 

1.82

%  

1.82

%

Expected Life

 

5.00

years

7.00

years

Expected Volatility

 

152

%  

159

%

Expected Dividend Yield

 

0

%  

0

%

 

Schedule of restricted stock activity

The following is a summary of restricted stock activity for the six months ended June 30, 2019 and June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted- Average

 

 

Number of

 

Weighted- Average

 

Remaining

 

    

Shares

    

Grant Date Fair Value

    

Recognition Period

Nonvested Outstanding at December 31, 2018

 

1,822,132

 

$

0.59

 

  

Vested

 

(12,773)

 

 

1.52

 

  

Forfeited

 

(3,141)

 

$

1.52

 

 

Nonvested Outstanding at June 30, 2019

 

1,806,218

 

$

0.58

 

1.77

Nonvested Outstanding at December 31, 2017

 

103,000

 

 

1.52

 

  

Vested

 

(45,490)

 

 

1.52

 

  

Nonvested Outstanding at June 30, 2018

 

57,510

 

$

1.52

 

1.60

 

Schedule of stock based compensation expense

The total stock-based compensation expense for employees and non-employees is included in the accompanying Condensed Consolidated Statements of Operations and as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 

 

June 30, 

 

    

2019

    

2018

    

2019

    

2018

Research and Development

 

$

58,611

 

$

49,897

 

$

123,150

 

$

106,975

General and Administrative

 

 

177,579

 

 

95,412

 

 

345,946

 

 

183,881

Total Stock-Based Compensation Expense

 

$

236,190

 

$

145,309

 

$

469,096

 

$

290,856